Immix Biopharma, Inc.
IMMX
Revenue
20.00M
▲20.00M∞%
-Assets
28.84M
▼-5.51M▼-16.05%
3 Months ChangeLiabilities
4.94M
▼-1.77M▼-26.37%
3 Months ChangeFree Cash Flow
-4.13M
▼-3.86M▼-1444.92%
36 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-12
Form 10-Q
ID: 0001493152-24-031358
2024-07-26
Form 8-K
ID: 0001493152-24-029174
2024-07-22
Form 8-K
ID: 0001493152-24-028595
2024-06-14
Form 8-K
ID: 0001493152-24-023947
2024-05-20
Form 8-K
ID: 0001493152-24-020785
2024-05-09
Form 10-Q
ID: 0001493152-24-018458
2024-02-06
Form 8-K
ID: 0001493152-24-005043
2024-02-05
Form 8-K
ID: 0001493152-24-004933
2023-11-13
Form 10-Q
ID: 0001493152-23-040182
2023-08-22
Form 8-K
ID: 0001493152-23-029822